Combination therapy for osteoporosis.

12-06-2001 дата публикации

Номер:

AP0000000975A

Автор: KE HUAZHU, THOMPSON DAVID DUANE, KE HUAZHU, THOMPSON DAVID DUANE, KE HuaZhu, THOMPSON David Duane

Принадлежит: Pfizer

Контакты:

Номер заявки: 01-00-2000962

Дата заявки: 27-02-1997

[1]

[2]

[3]

[4]

[5]

[6]

[7]

[8]

[9]

[10]

[11]

[12]

[13]

[14]

[15]

[16]

[17]

[18]

[19]

[20]

[21]

[22]

[23]

[24]

[25]

[26]

[27]

[28]

[29]

[30]

[31]

[32]

[33]

[34]

[35]

[36]

[37]

[38]

[39]

[40]

[41]

[42]

[43]

[44]

[45]

[46]

[47]

[48]

[49]

[50]

[51]

[52]

[53]

[54]

[55]

Pharmaceutical combination compositions including certain estrogen agonists/antagonists and prostaglandins or prostaglandin agonists/antagonists. The compositions are useful for the treatment of bone disorders including osteoporosis.

CPC - классификация

A A6 A61 A61K A61K3 A61K31 A61K31/A61K31/4 A61K31/40 A61K31/44 A61K31/445 A61K31/45 A61K31/453 A61K31/4535 A61K31/47 A61K31/5 A61K31/55 A61K31/557 A61K38 A61K38/A61K38/2 A61K38/27 A61K38/29 A61K4 A61K45 A61K45/A61K45/0 A61K45/06 A61P A61P1 A61P19 A61P19/A61P19/0 A61P19/00 A61P19/08 A61P19/1 A61P19/10 A61P3 A61P3/A61P3/0 A61P3/02 A61P4 A61P43 A61P43/A61P43/0 A61P43/00 Y Y1 Y10 Y10S Y10S4 Y10S43 Y10S435 Y10S435/Y10S435/9 Y10S435/97 Y10S435/975

IPC - классификация

A A6 A61 A61K A61K3 A61K31 A61K31/A61K31/1 A61K31/13 A61K31/135 A61K31/138 A61K31/4 A61K31/40 A61K31/41 A61K31/43 A61K31/437 A61K31/44 A61K31/443 A61K31/4439 A61K31/445 A61K31/4453 A61K31/45 A61K31/453 A61K31/4535 A61K31/47 A61K31/472 A61K31/4725 A61K31/49 A61K31/495 A61K31/5 A61K31/55 A61K31/557 A61K33 A61K33/A61K33/1 A61K33/16 A61K38 A61K38/A61K38/2 A61K38/22 A61K38/27 A61K38/29 A61K4 A61K45 A61K45/A61K45/0 A61K45/00 A61K45/06 A61P A61P1 A61P19 A61P19/A61P19/0 A61P19/08 A61P19/1 A61P19/10 A61P3 A61P3/A61P3/0 A61P3/02 A61P4 A61P43 A61P43/A61P43/0 A61P43/00 C C0 C07 C07D

Цитирование НПИ

EP0635270 A1
[ ] JOURNAL OF BONE AND MINERAL RESEARCH, vol. II, Aug. 1996, pp.96

Получить PDF